GBIO
Price
$0.36
Change
-$0.00 (-0.00%)
Updated
Jun 26, 01:20 PM (EDT)
Capitalization
24.45M
41 days until earnings call
XOMA
Price
$27.33
Change
-$0.12 (-0.44%)
Updated
Jun 26, 12:56 PM (EDT)
Capitalization
328.49M
41 days until earnings call
Interact to see
Advertisement

GBIO vs XOMA

Header iconGBIO vs XOMA Comparison
Open Charts GBIO vs XOMABanner chart's image
Generation Bio
Price$0.36
Change-$0.00 (-0.00%)
Volume$100
Capitalization24.45M
XOMA Royalty
Price$27.33
Change-$0.12 (-0.44%)
Volume$100
Capitalization328.49M
GBIO vs XOMA Comparison Chart in %
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. XOMA commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a Buy and XOMA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (GBIO: $0.36 vs. XOMA: $27.45)
Brand notoriety: GBIO and XOMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 114% vs. XOMA: 107%
Market capitalization -- GBIO: $24.45M vs. XOMA: $328.49M
GBIO [@Biotechnology] is valued at $24.45M. XOMA’s [@Biotechnology] market capitalization is $328.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileXOMA’s FA Score has 1 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • XOMA’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMA is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 3 TA indicator(s) are bullish while XOMA’s TA Score has 4 bullish TA indicator(s).

  • GBIO’s TA Score: 3 bullish, 6 bearish.
  • XOMA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, XOMA is a better buy in the short-term than GBIO.

Price Growth

GBIO (@Biotechnology) experienced а +1.31% price change this week, while XOMA (@Biotechnology) price change was +11.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

GBIO is expected to report earnings on Aug 06, 2025.

XOMA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XOMA($328M) has a higher market cap than GBIO($24.4M). XOMA YTD gains are higher at: 4.452 vs. GBIO (-65.594). XOMA has higher annual earnings (EBITDA): 6M vs. GBIO (-69.2M). GBIO has more cash in the bank: 158M vs. XOMA (92.6M). GBIO has less debt than XOMA: GBIO (87.6M) vs XOMA (114M). GBIO has higher revenues than XOMA: GBIO (24.6M) vs XOMA (13M).
GBIOXOMAGBIO / XOMA
Capitalization24.4M328M7%
EBITDA-69.2M6M-1,153%
Gain YTD-65.5944.452-1,473%
P/E RatioN/AN/A-
Revenue24.6M13M189%
Total Cash158M92.6M171%
Total Debt87.6M114M77%
FUNDAMENTALS RATINGS
XOMA: Fundamental Ratings
XOMA
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOXOMA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 24 days ago
85%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 14 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FUFRX24.32N/A
N/A
Franklin Utilities R6
FSTLX33.15N/A
N/A
Federated Hermes MDT Large Cap Value R6
NSFJX13.33N/A
N/A
Natixis Target Retirement 2045 N
FIKJX17.24N/A
N/A
Fidelity Advisor Real Estate Z
MSGLX12.07N/A
N/A
MassMutual Small Cap Gr Eq Adm

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-1.51%
CCCC - GBIO
50%
Loosely correlated
-1.28%
ATXS - GBIO
49%
Loosely correlated
-1.91%
IDYA - GBIO
48%
Loosely correlated
+1.06%
FHTX - GBIO
48%
Loosely correlated
+0.62%
IPSC - GBIO
47%
Loosely correlated
-4.74%
More

XOMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
-0.51%
SYRE - XOMA
39%
Loosely correlated
+2.01%
OCUL - XOMA
38%
Loosely correlated
+1.10%
GBIO - XOMA
38%
Loosely correlated
-1.51%
NAUT - XOMA
37%
Loosely correlated
+10.50%
ZNTL - XOMA
37%
Loosely correlated
-2.96%
More